Asthma

Researchers explore new ways to forecast thunderstorm-related asthma

CHASE 3 data support FDA approval of Symbicort in children 6 to >12 years.

ICS use associated with 83% increase in rate of pneumonia hospitalization

Maternal smoking may be more likely than birth age to cause asthma in kids.

Already at war over PCSK9, drug giants go to court over another breakthrough drug.

The FDA contraindicated using LABA as monotherapy in adults with asthma.

Newfound association a step towards creating cytokine profiles for asthma phenotypes.

Reslizumab can improve lung functions in certain asthmatic patients.

Meredith McCormack, MD, MHS, talked about managing asthma and COPD in the primary care setting and when it’s time to refer a patient to a specialist at the American College of Physicians Internal Medicine Meeting (ACP 2017) in San Diego, California.

Asthma responds differently to specific treatment regimens based on subtypes.

Omalizumab therapy reduces exacerbations in severe allergic asthma patients.

Highly anticipated potential first-line treatment now a go in the United States.

Reassessing asthma diagnoses in adults with asthma can help with overmedication.

Study found link between adult-onset asthma and exposure to cleaning products.

Many patients treated for severe asthma had not been properly assessed.

A new asthma study tested the clinical capabilities of Apple's ResearchKit.

RV/TCL ratios have a stronger association with longer duration asthma.

Genetics might not impact the efficacy of inhaled corticosteroid use in asthma.

John Kelso, MD, Division of Allergy, Asthma, and Immunology, Scripps Clinic, San Diego, explained the concerns researchers had of administering vaccines to patients experiencing allergic reactions to those vaccines.

Vitamin E deficiency in mothers can affect their children's risk of asthma.

Amy Scurlock, MD, Arkansas Children's Hospital, and team conducted a study looking at walnut oral immunotherapy in children with tree nut allergies.

"Not only has it shown efficacy in atopic dermatitis, but dupilumab also has shown efficacy in related atopic dermatitis conditions such as asthma and nasal polyps," said Akinlade.

Bola Akinlade, MD, MBA, Executive Director, Regeneron Pharmaceuticals, discussed the results of the dupilumab study presented at AAAAI 2017.

The phase 3b MUSCA trial reported positive results for mepolizumab.

Do emergency department physicians follow the asthma care guidelines?

Jay Jin, MD, PhD, Mayo Clinic, shared the results from his team's case series surrounding unexpected bradycardia effect from epinephrine administration.

Females were less likely to be compliant, a contradiction to previous research.

Mark S. Forshag, MD, MHA, with GSK, shared some of his team's next steps in advancing asthma care specifically with trying to keep things simple for the patients and their physicians.

Mark S. Forshag, MD, MHA, GSK, spoke with MD Magazine at AAAAI 2017 in Atlanta, GA, about the importance of eosinophils in treating severe asthma.

Would carrying a rescue inhaler correlate with better asthma control? That's what Sima J. Patel, DO and her team sought to investigate.